Compare MGM Resorts International (MGM) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MGM Resorts International vs Revvity Inc — how do they compare? MGM Resorts International trades at $29.3 (market cap $7.55B), while Revvity Inc trades at $154.1 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 2.2× MGM Resorts International's market cap, and Revvity Inc pays the higher dividend (0.18%). Which is the better fit depends on your goals — on Pluang, investors hold MGM Resorts International for 91 Days and Revvity Inc for 12 Days on average.
| MGM | RVTY | |
|---|---|---|
Market Cap | $7.55B | $16.98B |
Volume | 5,342,346 | 1,456,900 |
Sector | Consumer Cyclical | Health |
52-Week High | $50.69 | $157.36 |
52-Week Low | $30.00 | $82.26 |
Typical Hold Time | 91 Days | 12 Days |
Enterprise Value | $34.85B | $19.30B |
Dividend Yield | 0.03% | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MGM Resorts International (MGM) trades at $29.77, down 0.77% for the day amid a bearish technical signal and recent deal uncertainty. The stock has faced pressure after Barry Diller's People Inc. withdrew its $48.30 per share acquisition proposal in September 2026, contributing to a 17% decline year-to-date. Fundamentally, revenue grew to $17.54 billion in 2025, but net income margin compressed to 2.4%, while valuation metrics like a P/E of 18.19 and P/S of 0.45 suggest moderate pricing relative to sales. Analyst consensus remains bullish with a $48.75 price target, but technical indicators show selling pressure with key support at $29.
The outlook for MGM hinges on earnings execution and strategic moves, with Q3 2026 results due October 28 offering a near-term catalyst. Risks include volatile cash flows, high debt levels, and integration challenges from potential M&A. The stock's current discount to analyst targets presents opportunity if operational improvements materialize, but investors face headwinds from competitive pressures and macroeconomic sensitivity.
RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.
The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Cosmopolitan, Luxor, New York-New York, and CityCenter. The Strip contributed approximately 49% of total EBITDAR in the prepandemic year of 2019. MGM also owns U.S. regional assets, which represented 29% of 2019 EBITDAR. we estimate MGM's U.S. sports and iGaming operations are currently a mid-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM Macau casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2027.
Read more on MGM →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
